EGFR and cancer: SIAHON expression indicates persistent EGFR/RAS/RAF/MEK/MAPK pathway activation and cancer cell proliferation and predicts for tumor progression, whereas SIAHOFF expression indicates EGFR/RAS/RAF/MEK/MARK pathway inactivation, diminished cell proliferation, and tumor regression [142,276].